Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Novel Arf1 Inhibitors Drive Cancer Stem Cell Aging and Potentiate Anti-Tumor Immunity
  2. Wang, Yuetong; Li, Qiaoming; Ding, Yahui; Luo, Chenfei; Yang, Jun; Wang, Na; Jiang, Ning; Yao, Tiange; Wang, Guohao; Shi, Guoming; Hou, Steven X
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, Sep 03; e2404442.
  1. 2.   Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris
  2. Jin, Ye; Meng, Xue; Qiu, Zhidong; Su, Yanping; Yu, Peng; Qu, Peng
  3. Saudi Journal of Biological Sciences. 2018, Jul; 25(5): 991-995.
  1. 3.   A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids
  2. Malhotra, S. V.; Kumar, V.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(2): 581-585.
  1. 4.   A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent
  2. Kong, Y. L.; Wang, K.; Edler, M. C.; Hamel, E.; Mooberry, S. L.; Paige, M. A.; Brown, M. L.
  3. Bioorganic & Medicinal Chemistry. 2010, Jan; 18(2): 971-977.
  1. 5.   Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids
  2. Kumar, V.; Malhotra, S. V.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(16): 4643-4646.
  1. 6.   Synthesis and biological activity of 5-aza-ellipticine derivatives
  2. Moody, D. L.; Dyba, M.; Kosakowska-Cholody, T.; Tarasova, N. I.; Michejda, C. I.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Apr; 17(8): 2380-2384.
  1. 7.   Antibodies to CD40 promote dendritic cell recovery and anti-tumor effects after syngeneic bone marrow transplant (BMT)
  2. Welniak, L. A.; Berner, V.; Blazar, B. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Blood. 2005, NOV 16; 106(11, Part 1): 379A, Abstract 1305-379A, Abstract 1305.
  1. 8.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 9.   Mouse Ly49 NK receptors: balancing activation and inhibition
  2. Ortaldo, J. R.; Young, H. A.
  3. Molecular Immunology. 2005, FEB; 42(4): 445-450.
  1. 10.   Low total body irradiation (TBI) augments the synergistic anti-tumor effects of anti-CD40 and IL2 immunotherapy
  2. Sun, K.; Welniak, L. A.; Wiltrout, R.; Blazar, B. R.; Murphy, W. J.
  3. Journal of Immunotherapy. 2004, NOV-DEC; 27(6): S19-S19.
  1. 11.   Cellular pharmacology studies of shikonin derivatives
  2. Chen, X.; Yang, L.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Phytotherapy Research. 2002 16(3): 199-209.
  1. 12.   The diverse role of chemokines in tumor progression: Prospects for intervention (Review)
  2. Schneider, G. P.; Salcedo, R.; Welniak, L. A.; Howard, O. M. Z.; Murphy, W. J.
  3. International Journal of Molecular Medicine. 2001 8(3): 235-244.
  1. 13.   Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30
  2. Lee-Huang, S.; Huang, P. L.; Sun, Y. T.; Chen, H. C.; Kung, H. F.; Murphy, W. J.
  3. Anticancer Research. 2000 20(2A): 653-659.
  1. 14.   Expression and Characterization of a Cytotoxic Human-Frog Chimeric Ribonuclease - Potential For Cancer Therapy
  2. Newton, D. L.; Xue, Y.; Boque, L.; Wlodawer, A.; Kung, H. F.; Rybak, S. M.
  3. Protein Engineering. 1997 10(4): 463-470.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel